| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cutting-edge solution to a Gordian knot? Aptamers targeting cancer stem cell markers for strategic cancer therapy
|
Muzaffar, Aneesa
|
|
|
30 |
5 |
p.
|
artikel
|
| 2 |
Advances in artificial intelligence-envisioned technologies for protein and nucleic acid research
|
Gholap, Amol D.
|
|
|
30 |
5 |
p.
|
artikel
|
| 3 |
Advancing ocular gene therapy: a machine learning approach to enhance delivery, uptake and gene expression
|
Aghajanpour, Sareh
|
|
|
30 |
5 |
p.
|
artikel
|
| 4 |
An overview of progress in human metapneumovirus (hMPV) research: Structure, function, and therapeutic opportunities
|
Krüger, Nadine
|
|
|
30 |
5 |
p.
|
artikel
|
| 5 |
Are leukotrienes really the world’s best bronchoconstrictors and at least 100 to 1000 times more potent than histamine?
|
Boehm, Thomas
|
|
|
30 |
5 |
p.
|
artikel
|
| 6 |
Artificial intelligence in preclinical research: enhancing digital twins and organ-on-chip to reduce animal testing
|
Gangwal, Amit
|
|
|
30 |
5 |
p.
|
artikel
|
| 7 |
Computational modeling approaches and regulatory pathways for drug combinations
|
Fillinger, Lucas
|
|
|
30 |
5 |
p.
|
artikel
|
| 8 |
Corrigendum to “Benchmarking R&D success rates of leading pharmaceutical companies: an empirical analysis of FDA approvals (2006–2022)” [Drug Discov. Today 30(2) (2025) 104291]
|
Schuhmacher, Alexander
|
|
|
30 |
5 |
p.
|
artikel
|
| 9 |
Corrigendum to “Role of transient receptor potential channels in the regulation of vascular tone” [Drug Discov. Today 29(7) (2024) 104051]
|
Hu, Xiang-Qun
|
|
|
30 |
5 |
p.
|
artikel
|
| 10 |
Covalent inhibitors possessing autophagy-modulating capabilities: charting novel avenues in drug design and discovery
|
Wang, Yutong
|
|
|
30 |
5 |
p.
|
artikel
|
| 11 |
DCTPP1: A promising target in cancer therapy and prognosis through nucleotide metabolism
|
Liu, Shaoxuan
|
|
|
30 |
5 |
p.
|
artikel
|
| 12 |
Evaluation of the implementation effectiveness of accelerated drug marketing registration procedures in China: lessons from the 2016–2024 regulatory review
|
Lan, Yipeng
|
|
|
30 |
5 |
p.
|
artikel
|
| 13 |
Every Compound a Candidate: experience-led risk-taking approaches to accelerate small-molecule drug discovery
|
McGinnity, Dermot F.
|
|
|
30 |
5 |
p.
|
artikel
|
| 14 |
JAK inhibitors as a promising therapy for immune-mediated photodermatoses
|
Malekan, Mohammad
|
|
|
30 |
5 |
p.
|
artikel
|
| 15 |
Leveraging mHealth wearables for managing patients with Alzheimer’s disease: a scoping review
|
Noda, Kenta
|
|
|
30 |
5 |
p.
|
artikel
|
| 16 |
Long-term follow-up after authorization of gene therapy: leveraging real-world data
|
de Haart, Karin
|
|
|
30 |
5 |
p.
|
artikel
|
| 17 |
Pathogenic TDP-43 in amyotrophic lateral sclerosis
|
Chong, Zhao Zhong
|
|
|
30 |
5 |
p.
|
artikel
|
| 18 |
Selective imaging probes for differential detection of pathological tau polymorphs in tauopathies
|
Bisi, Nicolò
|
|
|
30 |
5 |
p.
|
artikel
|
| 19 |
Targeting FLT3 for treating diseases: FLT3 inhibitors
|
Rong, Qing-Yun
|
|
|
30 |
5 |
p.
|
artikel
|
| 20 |
Target & Mechanism Selection in Pharmaceutical Innovation: A Source for Concern or Optimism?
|
Kinch, Michael S.
|
|
|
30 |
5 |
p.
|
artikel
|
| 21 |
The connection between Bayesian networks and adverse outcome pathway (AOP) networks and how to use it for predicting drug toxicity
|
Wang, Dong
|
|
|
30 |
5 |
p.
|
artikel
|
| 22 |
Therapeutic potential of targeting ubiquitin-specific proteases in colorectal cancer
|
Oon, Chern Ein
|
|
|
30 |
5 |
p.
|
artikel
|
| 23 |
The spindle assembly checkpoint: Molecular mechanisms and kinase-targeted drug discovery
|
Lima, Inês
|
|
|
30 |
5 |
p.
|
artikel
|
Tijdschrift beschrijving